CINECA IRIS Institutional Research Information System

BIOLATTI, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.050
EU - Europa 2.633
AS - Asia 1.096
AF - Africa 84
OC - Oceania 48
SA - Sud America 47
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.959
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.977
IT - Italia 1.063
CN - Cina 479
IE - Irlanda 337
SE - Svezia 259
DE - Germania 187
GB - Regno Unito 159
JP - Giappone 129
FR - Francia 111
AT - Austria 105
VN - Vietnam 94
UA - Ucraina 90
IN - India 75
KR - Corea 72
FI - Finlandia 65
HK - Hong Kong 64
CA - Canada 52
PL - Polonia 47
SG - Singapore 44
AU - Australia 41
NL - Olanda 35
BE - Belgio 33
TR - Turchia 33
SN - Senegal 29
GR - Grecia 26
IL - Israele 23
ES - Italia 19
IR - Iran 19
TW - Taiwan 19
UG - Uganda 18
DK - Danimarca 17
MX - Messico 17
ZA - Sudafrica 16
RU - Federazione Russa 14
CO - Colombia 13
IQ - Iraq 12
NO - Norvegia 12
BR - Brasile 10
PK - Pakistan 10
RO - Romania 10
SI - Slovenia 10
PH - Filippine 9
TN - Tunisia 9
AR - Argentina 7
HR - Croazia 7
NZ - Nuova Zelanda 7
PE - Perù 7
CH - Svizzera 6
CL - Cile 4
PR - Porto Rico 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
LU - Lussemburgo 3
MA - Marocco 3
NG - Nigeria 3
PT - Portogallo 3
ZM - Zambia 3
BD - Bangladesh 2
BG - Bulgaria 2
BY - Bielorussia 2
EC - Ecuador 2
GY - Guiana 2
ID - Indonesia 2
MY - Malesia 2
SA - Arabia Saudita 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
GH - Ghana 1
IS - Islanda 1
JO - Giordania 1
LB - Libano 1
MU - Mauritius 1
NP - Nepal 1
UY - Uruguay 1
YE - Yemen 1
Totale 7.959
Salva come PNG Salva come JPEG
Città #
Chandler 849
Dublin 333
Torino 205
Fairfield 180
Beijing 170
Ann Arbor 129
Houston 120
Ashburn 117
Woodbridge 116
Sovicille 115
Nyköping 114
Redwood City 100
Vienna 98
Jacksonville 91
Wilmington 85
Turin 83
Princeton 81
Cambridge 79
Medford 72
Pisa 70
Seattle 69
Dong Ket 65
Dearborn 62
Villeurbanne 59
Guangzhou 54
Boston 46
Los Angeles 46
Rome 43
Fremont 41
Warsaw 36
Washington 33
New York 31
Milan 28
Norwalk 26
Higashiayase 25
Hebei 24
Shanghai 23
Tokyo 23
Maddaloni 22
Rochester 21
San Diego 21
Pittsburgh 20
Taipei 19
Kampala 18
Brussels 16
San Mauro Torinese 16
Wuhan 16
Elk Grove Village 15
Gongju 15
Helsinki 15
Boardman 14
Hangzhou 14
Seoul 14
Singapore 14
Thebes 14
Nanjing 13
Toronto 13
Bogotá 12
Hefei 12
Ipswich 12
London 12
Munich 12
Piemonte 12
Aarhus 11
Central 11
Melbourne 11
San Mateo 11
Birmingham 10
Dallas 10
Hanover 10
Istanbul 10
Blackwood 9
Casteggio 9
Florence 9
Johannesburg 9
Lincoln 9
Ottawa 9
Philadelphia 9
Utrecht 9
Boffalora sopra Ticino 8
Changsha 8
Chicago 8
Fossano 8
Hamburg 8
Leeds 8
Novara 8
Tel Aviv 8
West Point 8
Berlin 7
Bethesda 7
Chapel Hill 7
Kahramanmaraş 7
Kraainem 7
Kunming 7
Minneapolis 7
Oslo 7
Padova 7
Suri 7
Vaasa 7
Vercelli 7
Totale 4.635
Salva come PNG Salva come JPEG
Nome #
The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion 330
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 310
Biological relevance of Cytomegalovirus genetic variability in congenitally and postnatally infected children. [*Dell'Oste V, *Landolfo S, co-corresponding authors] 259
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 216
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 209
PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. 197
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 175
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 168
The human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS 167
Modulation of the innate immune response by human cytomegalovirus. [*Dell'Oste V., Landolfo S. co-corresponding authors] 165
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability [*Biolatti M, *Dell'Oste V, co-first authors] 163
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 162
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 155
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 152
Genotypic analysis of HCMV polymorphism in congenital infections to predict the impact of HCMV disease severity in newborns/infants 151
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 141
Catch me if you can: the arms race between human cytomegalovirus and the innate immune system [Ganna Galitska*, Matteo Biolatti*, equal contribution) 135
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 125
Evasion strategy of Human Cytomegalovirus from the antiviral activities of APOBEC3G 125
Strigolactone analogs are promising antiviral agents against Herpesviruses 121
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 117
Past and ongoing adaptation of human cytomegalovirus to its host. 116
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 115
Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability 113
A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits. 111
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 109
Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity 105
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 101
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 100
HPV meets APOBEC: New players in head and neck cancer [*Biolatti M, Dell'Oste V* co-last authors]. 100
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 98
Where do we stand after decades of studying human cytomegalovirus? 97
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis 95
A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligands immunomodulation 94
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 88
IFI16 is a Negative Regulator of Glucose and Cellular Lipid Metabolism during Human Cytomegalovirus Infection 87
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 86
Evasion Strategy of Human Cytomegalovirus to Escape Interferon-β-Induced APOBEC3G Editing Activity 86
COMPARATIVE ANALYSIS OF HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATES FROM KIDNEY TRANSPLANT RECIPIENTS 83
HCMV TEGUMENT PROTEINS: NEW INSIGHTS ON INTERACTION BETWEEN THE DNA SENSOR PROTEIN IFI16 AND VIRION PARTICLES 83
Tuning the Orchestra: HCMV vs. Innate Immunity. 81
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection. 81
Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses [*Valentina Dell'Oste, Daniele Castagnolo: co-corresponding authors] 79
Human Cytomegalovirus and Autoimmune Diseases: Where Are We? 79
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 77
Risk of Symptomatic Infection after Non-Primary Congenital Cytomegalovirus Infection 77
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 76
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 75
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability 73
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 72
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 71
Peptidyl Arginine Deiminases: a Novel Antiviral Target against Human Cytomegalovirus 68
PAD2 FOR USE IN DIAGNOSING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY AND INHIBITORS OR ANTAGONISTS OF PAD2 FOR USE AS ANTI-VIRAL AGENTS AGAINST VIRUSES OF THE HERPESVIRIDAE FAMILY 68
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 65
SAMHD1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity 65
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 65
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting the main protease Mpro 63
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease. 63
PYHIN Proteins and HPV: Role in the Pathogenesis of Head and Neck Squamous Cell Carcinoma 62
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 62
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 61
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 57
Metabolic games: IFI16-driven regulation of cellular metabolism upon HCMV infection 57
45th International Herpesvirus Workshop 57
Targeting PAD-mediated citrullination to treat human papillomavirus infections 55
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 54
STRIGOLACTONES FOR USE IN PREVENTING AND/OR TREATING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY 53
Strigolactone analogs are promising antiviral agents for the treatment of human cytomegalovirus infection 50
Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ 49
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 49
THE GENETIC VARIABILITY OF HUMAN CITOMEGALOVIRUS: POSSIBLE IMPLICATIONS IN CLINICAL, IMMUNOLOGICAL AND VIROLOGICAL SETTINGS 47
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection 45
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting SARS-CoV-2 Mpro 44
Strigolactones as broad-spectrum antivirals against ß-coronaviruses through targeting the main protease Mpro 44
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 44
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 41
Targeting PAD-mediated citrullination to treat human papillomavirus infections 38
CONGENITAL CYTOEGALOVIRUS INFECTION: CAN THE DIFFERENCE BETWEEN THE VIRUS’ RELATIONSHIP WITH THE HOST’S IMMUNE SYSTEM EXPLAIN THE DIFFERENCE IN CLINICAL PHENOTYPES? 38
50° Congresso Nazionale della Società Italiana di Microbiologia 34
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 31
La variabilità genetica del citomegalovirus umano: possibili implicazioni dal punto di vista clinico, immunologico e virologico 31
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 31
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 30
IFI16 Impacts Metabolic Reprogramming During Human Cytomegalovirus Infection 24
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro 20
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease. 15
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease 13
Citrullination upon viral infection: a new strategy for host-targeting antivirals drugs 12
Exploiting Lipid Metabolism by HSV-1: a Challenge to Rethink New Therapies for Alzheimer’s Disease 11
Replication properties and immunomodulatory effects of human cytomegalovirus infection impact the clinical presentation in congenital patients: A case series [*Valentina Dell'Oste: corresponding author] 11
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 7
Characterization of citrullination during infection with DNA and RNA viruses: a new strategy for host-targeting antivirals drugs 7
Herpesvirus-mediated protein citrullination as a new target for antiviral therapy 7
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 6
Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors 6
Antiherpetic Activity of a Root Exudate from Solanum lycopersicum [*Valentina Dell'Oste, Marco Blangetti co-corresponding authors; † Greta Bajetto, Davide Arnodo co-first authors] 5
PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer 3
Antimicrobial Efficacy of a Vegetable Oil Plasticizer in PVC Matrices 2
Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism 1
Totale 8.222
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.942
article - articoli 0
book - libri 0
conference - conferenze 12.965
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.907
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019149 0 0 0 0 0 0 0 0 0 0 98 51
2019/2020852 18 21 52 102 38 110 91 68 77 104 71 100
2020/20211.166 72 69 66 58 97 118 132 75 84 152 67 176
2021/20221.294 75 71 91 128 70 54 61 69 45 92 324 214
2022/20232.390 130 143 56 279 255 537 118 211 323 71 138 129
2023/20241.091 167 164 95 62 122 161 100 92 24 102 2 0
Totale 8.222